Nivolumab/pembrolizumabVarious toxicities: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1863卷 / 1期

关键词：

D O I：

10.1007/s40278-021-98882-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：278 / 278

相关论文

共 50 条

[1] Nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2020, 1799 (1) : 295 - 295
[2] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2017, 1648 (1) : 170 - 170
[3] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2020, 1801 (1) : 154 - 154
[4] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2022, 1887 (1) : 399 - 399
[5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2021, 1845 (1) : 220 - 220
[6] Ipilimumab/Nivolumab/PembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2024, 2030 (1) : 243 - 244
[7] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1848 (1) : 310 - 310
[8] Nivolumab/pembrolizumabVarious toxicities: 116 case reports
Reactions Weekly, 2016, 1611 (1) : 132 - 132
[9] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1786 (1) : 131 - 131
[10] Nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1858 (1) : 314 - 314

← 1 2 3 4 5 →